Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients-Reference-Cited by-同舟云学术

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients

Published:2002-05 Issue:9 Volume:73 Page:1514-1518
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Peddi V. Ram,Bryant Margaret,Roy-Chaudhury Prabir,Woodle E. Steve,First M. Roy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference7 articles.

1. A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VERSUS ATGAM FOR INDUCTION IMMUNOSUPPRESSIVE THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS1,2

2. RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

3. Immunologically high-risk recipient strategies

4. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rejection in Liver Transplantation Recipients;Journal of Clinical and Experimental Hepatology;2024-07

2. Effect of Different Induction Immunosuppression on the Incidence of Infectious Complications after Kidney Transplantation—Single Center Study;Journal of Clinical Medicine;2024-04-09

3. Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection;World Journal of Transplantation;2023-12-18

4. Single-dose antithymocyte globulin in standard immunological risk kidney transplant recipients: efficacy and kinetics of peripheral blood CD3+ T lymphocyte modulation;Journal of Nephrology;2023-11-09

5. Immunosuppression in Pediatric Kidney Transplantation;Pediatric Kidney Disease;2023